Brief: Seelos Therapeutics Provides Clinical Update And Reports First Quarter 2023 Financial Results
Seelos Therapeutics Inc SEEL.O :
* SEELOS THERAPEUTICS PROVIDES CLINICAL UPDATE AND REPORTS
FIRST
QUARTER 2023 FINANCIAL RESULTS
* AS OF MARCH 31, 2023, TOTAL CASH AND CASH EQUIVALENTS WERE
$14.1
MILLION
* QTRLY NET LOSS PER SHARE $0.12
* Q1 EARNINGS PER SHARE VIEW $-0.11 -- REFINITIV IBES DATA
Source text for Eikon: ID:nPn6PGv6ra
Further company coverage: SEEL.O
Recent news on Seelos Therapeutics
See all newsBrief: Seelos Therapeutics Commences Chapter 11 Proceedings- Court Filing
Brief: Seelos Therapeutics Announces Notice Of Delisting From Nasdaq And Transfer Of Listing To Over-The-Counter Market
Brief: Seelos Announces Postponement Of Its Annual Meeting Of Stockholders
Brief: Seelos Therapeutics Announces 1-For-16 Reverse Stock Split
U.S. STOCKS ON THE MOVE-Copper miners, Visa, Bluebird bio